Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
4.08
Aug 21 • 3:59 PM ET Dollar change-0.33 Percentage change(-7.38%)
Aftermarket Close
4.16
Aftermarket • 5:00 PM ET Dollar change+0.08 Percentage change(1.96%)
Index
-
Market Cap
44.31M
Enterprise Value
40.48M
Income
1.74M
Sales
20.72M
Book/sh
1.10
Cash/sh
0.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
36
IPO
Sep 21, 2004
P/E
26.07
Forward P/E
15.69
PEG
0.37
P/S
2.14
P/B
3.70
P/C
9.43
P/FCF
26.85
EV/EBITDA
22.87
EV/Sales
1.95
Quick Ratio
2.71
Current Ratio
4.07
Debt/Eq
0.07
LT Debt/Eq
0.04
Option/Short
No / Yes
EPS (ttm)
0.16
EPS next Y
0.26
EPS next Q
0.02
EPS this Y
42.42%
EPS next Y
65.96%
EPS next 5Y
42.75%
EPS past 3/5Y
- -
Sales past 3/5Y
23.50% 17.02%
EPS Y/Y TTM
28.29%
Sales Y/Y TTM
24.20%
EPS Q/Q
391.78%
Sales Q/Q
36.16%
Insider Own
13.37%
Insider Trans
0.00%
Inst Own
48.92%
Inst Trans
-0.67%
ROA
12.39%
ROE
16.10%
ROIC
13.97%
Gross Margin
60.66%
Oper. Margin
7.92%
Profit Margin
8.38%
SMA20
1.97%
SMA50
10.80%
SMA200
3.71%
Trades
Shs Outstand
10.86M
Shs Float
9.41M
52W High
6.42 -36.45%
52W Low
2.66 53.22%
Volatility
12.15% 9.96%
ATR (14)
0.39
RSI (14)
51.05
Beta
1.55
Rel Volume
6.17
Avg Volume
16.33K
Volume
100,709
Perf Week
-11.78%
Perf Month
8.22%
Perf Quarter
10.57%
Perf Half Y
0.00%
Perf YTD
-16.39%
Perf Year
1.49%
Perf 3Y
148.77%
Perf 5Y
-47.76%
Perf 10Y
19.30%
Prev Close
4.41
Price
4.08
Change %
-7.38%
Date Action Analyst Rating Change Price Target Change
Jul-17-26Initiated Northland Capital Market Perform $4
Jan-26-21Initiated B. Riley Securities Buy $12.50
Aug-07-26 08:30AM
01:11AM
Aug-06-26 04:10PM
Aug-05-26 04:00PM
Jul-20-26 07:00AM
07:00AM Loading…
Jul-06-26 07:00AM
Jun-18-26 07:00AM
Jun-16-26 07:00AM
May-08-26 08:30AM
May-07-26 04:05PM
Apr-30-26 04:00PM
Apr-16-26 09:57AM
Apr-01-26 09:00AM
Mar-13-26 09:02PM
08:30AM
04:10PM Loading…
Mar-12-26 04:10PM
Mar-05-26 07:04AM
Feb-13-26 08:16AM
Dec-11-25 09:00AM
Nov-10-25 08:04PM
Nov-06-25 04:10PM
Oct-30-25 04:00PM
Oct-08-25 09:00AM
Oct-07-25 10:41AM
Aug-08-25 11:00PM
Aug-07-25 04:00PM
Jul-31-25 04:00PM
Jul-15-25 09:19AM
May-28-25 09:00AM
May-08-25 04:00PM
11:46AM Loading…
May-07-25 11:46AM
Apr-30-25 04:00PM
Apr-28-25 09:00AM
Mar-06-25 04:00PM
Mar-05-25 07:36AM
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
PresidentMr. Robert Banks
Chief Financial OfficerMs. Judy F. Krandel C.F.A.
Director of BrandBrianne McGuire
Vice President of QualityVashone R. Thomas
President of Aether Water SystemsMr. Greg Lucas
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEXFORD CAPITAL LP10% OwnerAug 18 '26Option Exercise3.608122,92356,872Aug 20 04:14 PM
Banks Robert R. Jr.President and CEOMar 23 '26Option Exercise1.44120,000172,800190,000Mar 25 04:54 PM
Krandel JudyChief Financial OfficerMar 23 '26Option Exercise1.7168,861117,75268,861Mar 25 04:53 PM